FiteBac is protecting patients and revolutionizing dentistry with our new line of antimicrobial dental restorative materials. Founded in 2016, we began as a research-backed medical technology company and now, we have our own line of antimicrobial dental products, all powered by our internationally patented lead molecules, K18 and K21.
In the fall of 2020, we entered the market with the first-ever FDA-cleared antimicrobial cavity cleanser and that was only the beginning. We have additional devices under FDA review and even more devices being developed and studied at various institutions throughout the world.
And now, for the first time ever, we’re making our patented technology available to international manufacturers so the entire world can benefit!
Whatever you make, we want to help make it antimicrobial.
FiteBac is attending IDS 2021 with one main goal: announce the arrival of our antimicrobial additives and product materials to partner with manufacturers worldwide so patients and customers everywhere can benefit from this industry-changing technology.
With our antimicrobial agents, dental products and devices of all kinds can be made to be antimicrobial: adhesives, composites, sealants, bonding agents, cements, endodontic sealants, mouth rinses, dental glass, silica, resins, crowns, dentures, implants, mouth guards, night guards, retainers, orthodontic appliances, and resin-modified glass ionomers.
At FiteBac, our dream is to have a world where dental procedures are completed with antimicrobial products in every step of the process, providing maximum protection and maximum health for patients everywhere.